FI68048C - Foerfarande foer framstaellning av terapeutiskt anvaendbara sustituerade oxirankarboxylsyror - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara sustituerade oxirankarboxylsyror Download PDF

Info

Publication number
FI68048C
FI68048C FI802790A FI802790A FI68048C FI 68048 C FI68048 C FI 68048C FI 802790 A FI802790 A FI 802790A FI 802790 A FI802790 A FI 802790A FI 68048 C FI68048 C FI 68048C
Authority
FI
Finland
Prior art keywords
ethyl ester
acid
acid ethyl
phenyl
ester
Prior art date
Application number
FI802790A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI68048B (fi
FI802790A (fi
Inventor
Hermann Amschler
Klaus Eistetter
Gerhard Ludwig
Erich Rapp
Horst Wolf
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI802790A publication Critical patent/FI802790A/fi
Application granted granted Critical
Publication of FI68048B publication Critical patent/FI68048B/fi
Publication of FI68048C publication Critical patent/FI68048C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/72—Acyl halides containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/76—Acyl halides containing halogen outside the carbonyl halide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D301/00—Preparation of oxiranes
    • C07D301/02—Synthesis of the oxirane ring
    • C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/12—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Resins (AREA)
  • Saccharide Compounds (AREA)
FI802790A 1979-09-07 1980-09-05 Foerfarande foer framstaellning av terapeutiskt anvaendbara sustituerade oxirankarboxylsyror FI68048C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH806879 1979-09-07
CH806879 1979-09-07

Publications (3)

Publication Number Publication Date
FI802790A FI802790A (fi) 1981-03-08
FI68048B FI68048B (fi) 1985-03-29
FI68048C true FI68048C (fi) 1985-07-10

Family

ID=4334641

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802790A FI68048C (fi) 1979-09-07 1980-09-05 Foerfarande foer framstaellning av terapeutiskt anvaendbara sustituerade oxirankarboxylsyror

Country Status (21)

Country Link
US (1) US4324796A (ja)
EP (1) EP0025192B1 (ja)
JP (1) JPS5645464A (ja)
KR (1) KR840002306B1 (ja)
AT (1) ATE3291T1 (ja)
AU (1) AU534361B2 (ja)
CA (1) CA1149404A (ja)
DD (1) DD154017A5 (ja)
DE (2) DE3032669A1 (ja)
DK (1) DK380680A (ja)
ES (1) ES494791A0 (ja)
FI (1) FI68048C (ja)
GR (1) GR69822B (ja)
HU (1) HU183206B (ja)
IE (1) IE50998B1 (ja)
IL (1) IL60975A (ja)
NZ (1) NZ194850A (ja)
PL (1) PL129063B1 (ja)
PT (1) PT71773B (ja)
YU (1) YU226880A (ja)
ZA (1) ZA805499B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337267A (en) * 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
JPS57501478A (ja) * 1980-08-29 1982-08-19
DE3269811D1 (en) * 1981-07-24 1986-04-17 Byk Gulden Lomberg Chem Fab Phenylalkyloxirane-carboxylic acids, process for their preparation, their use and medicines containing them
DE3525284A1 (de) * 1985-07-16 1987-01-29 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten
WO1987000751A2 (en) * 1985-08-02 1987-02-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of oxirancarboxylic acids for the treatment of hyperlipemia
JPH0610053Y2 (ja) * 1986-09-24 1994-03-16 株式会社西製作所 受金具
KR890701585A (ko) * 1987-07-16 1989-12-21 헤르베르크 슈키·울리히 볼프 새로운 디아졸
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
WO1998000422A1 (en) * 1996-07-02 1998-01-08 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) * 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
JP2006519229A (ja) * 2003-02-13 2006-08-24 アルバート・アインシュタイン・カレッジ・オヴ・メディシン・オヴ・イェシヴァ・ユニヴァーシティ 視床下部内の長鎖脂肪アシルＣｏＡレベルの変調による摂食量およびグルコース産生量の調節
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
US20090012067A1 (en) * 2005-02-14 2009-01-08 Luciano Rossetti Modulation of Hypothalamic Atp-Sensitive Potassium Channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3967482A (en) * 1975-03-17 1976-07-06 American Can Company Production of closed bottom shells
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
CA1103260A (en) 1975-09-22 1981-06-16 Richard J. Mohrbacher .alpha.-ALKYL-SUBSTITUTED GLYCIDATES AND THIOGLYCIDATES
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives

Also Published As

Publication number Publication date
JPS6112907B2 (ja) 1986-04-10
PL226600A1 (ja) 1982-03-01
DD154017A5 (de) 1982-02-17
ES8105988A1 (es) 1981-07-01
FI68048B (fi) 1985-03-29
EP0025192B1 (de) 1983-05-11
ZA805499B (en) 1981-08-26
FI802790A (fi) 1981-03-08
IL60975A (en) 1984-03-30
KR830003462A (ko) 1983-06-20
PT71773B (de) 1982-03-26
ATE3291T1 (de) 1983-05-15
AU6209880A (en) 1981-03-12
DE3063144D1 (en) 1983-06-16
KR840002306B1 (ko) 1984-12-17
HU183206B (en) 1984-04-28
YU226880A (en) 1983-02-28
ES494791A0 (es) 1981-07-01
AU534361B2 (en) 1984-01-26
GR69822B (ja) 1982-07-13
PT71773A (de) 1980-10-01
DK380680A (da) 1981-03-08
NZ194850A (en) 1982-05-31
IL60975A0 (en) 1980-11-30
IE50998B1 (en) 1986-09-03
CA1149404A (en) 1983-07-05
DE3032669A1 (de) 1981-04-02
IE801861L (en) 1981-03-07
PL129063B1 (en) 1984-03-31
EP0025192A2 (de) 1981-03-18
US4324796A (en) 1982-04-13
JPS5645464A (en) 1981-04-25
EP0025192A3 (en) 1981-05-06

Similar Documents

Publication Publication Date Title
FI68048B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sustituerade oxirankarboxylsyror
DK171890B1 (da) Analogifremgangsmåde til fremstilling af phen(alk)oxyalkyl-substituerede oxirancarboxylsyrer eller derivater deraf og mellemprodukter til anvendelse som udgangsmaterialer ved fremgangsmåden
JP2002527501A (ja) 新規化合物、その製造及び利用
JP2002527503A (ja) 新規化合物類、それらの調製及び使用
JP2002527507A (ja) 新規化合物類、それらの調製及び使用
CZ280121B6 (cs) Éter 1-benzyl-3-hydroxymetylindazolu s alifytickými 2-hydroxykyselinami, způsob jeho přípravy, meziprodukt tohoto postupu a farmaceutický prostředek, obsahující uvedený éter
JPH01106839A (ja) アルカジエン誘導体類、それらの製造、およびそれらを含有している薬学的組成物
JPS59176284A (ja) ８−アルコキシ−６，７−ジヒドロ−５−メチル−９−フルオロ−１−オキソ−１Ｈ，５Ｈ−ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸
CZ280084B6 (cs) Deriváty 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanů způsob jejich přípravy a jejich terapeutické použití
IE55377B1 (en) 1,5-diphenylpyrazolin-3-one compounds,method for preparing them,and pharmaceutical compositions containing these compounds
US4205087A (en) Acetic acid derivatives
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
FI83958B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara, substituerade 8-tiotetrahydrokinoliner samt deras salter.
JPH02115166A (ja) ピリジルケトオキシムエーテル誘導体
Kluge et al. Tricyclic aryl-substituted anticoccidial azauracils
US4605654A (en) 2-(arylalkyloxymethyl)morpholines and the central nervous system compositions
JP2008512384A (ja) Ｐｐａｒアゴニスト活性を有するフィブラート化合物
US4333930A (en) Orthoarylideneaminophenethylamines and pharmaceutical compositions
NO792275L (no) Fremgangsmaate for fremstilling av farmakologisk aktive pyrazolo-pyridinderivater
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
WO1983000334A1 (en) Phenylalkyloxirane carboxylic acids, preparation and therapeutical use
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
EP0329124A2 (en) Metabolites of pentanedioic acid derivatives
KR100361834B1 (ko) 폴리에톡실레이티드 피라졸로피리미디논 유도체, 그의제조방법 및 그를 포함하는 발기부전증 치료용 약제학적조성물
JPH0363279A (ja) イミダゾベンゾジアゼピン類及びそれらの酸付加塩、それらの製造方法、それらを含有する製薬組成物並びにそれらの薬剤としての使用

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH